Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$3.21
-$0.17 (-5.03%)
$3.21Day Range$3.50
Key Statistics
Market Cap
$1.88M
Shares Outstanding
0.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 31, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$3.31
Day High
$3.50
Day Low
$3.21
Volume
24.3K
VWAP
$3.32
Prev Close
$3.38
Transactions
--
Acc. Volume
--
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
PHARMACEUTICAL PREPARATIONSSIC 28342 employees401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, 20879(240) 403-4212IPO Aug 31, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001757499
- Composite FIGI
- BBG017Z2NFJ1
- Share Class FIGI
- BBG017Z2NGC6
- Ticker Root
- SHPH
- SIC Code
- 2834
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock
Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) closed the 2026-09-18 session at $3.21, down 5.03% versus the previous close (-0.17). The stock opened at $3.31 and traded between $3.21 and $3.50 during that session. Session trading volume was 24K shares. The volume-weighted average price (VWAP) is $3.32.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Shuttle Pharmaceuticals Holdings, Inc. Common Stock has a market capitalization of $1.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SHPH is listed on the XNAS exchange. The company employs approximately 2 people. Shuttle Pharmaceuticals Holdings, Inc. Common Stock is headquartered in GAITHERSBURG, MD. The recorded listing date is 2022-08-31.
On this page you can find market SHPH stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.